Clinical Trial Update: A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation [Phase 2]

View source ↗

Summary

Phase 2, single-blind, dose-tapering trial of KWA-0711 for chronic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• KWA-0711

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Chronic Constipation | Phase 2 | Status: COMPLETED